Lakewood-Amedex Biotherapeutics Inc. (LABT) reporting calendar
Lakewood-Amedex Biotherapeutics Inc. files periodic reports with the SEC as LABT on Nasdaq. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 22 May 2026
- Reports on record
- 1
Open LABT market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 22 May 2026 | 52 days | 0001213900-26-060640 |
Source: SEC EDGAR company submissions for CIK 0002079272. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.